Future Creation Capital

Aeterlink is a developer of innovative wireless power transfer technology aimed at creating a digital landscape devoid of wires. The company specializes in applying its advanced technology across various sectors, including factory automation, robotics, smart homes, and healthcare. By enabling wireless power transmission over distances, Aeterlink's solutions enhance efficiency and sustainability while improving safety by eliminating the hazards associated with traditional wiring. Their practical level technologies facilitate greater flexibility in device placement and operation, contributing to a more connected and streamlined environment across multiple industries.

Gaudi Clinical specializes in regenerative medicine outsourcing and cell processing contract establishments.

SpeakBUDDY is a Tokyo-based developer of an English learning platform that offers a mobile and web app for individuals, corporates, and schools. Its core product combines an AI-powered English learning app with pronunciation checking and scenario-based content, alongside an online coaching service named SpartaBUDDY. The subscription-based platform provides curriculum creation tools and personalized practice to improve speaking and comprehension. Established in 2013, the company focuses on scalable language training that blends self-guided app use with professional coaching.

The Phage is a medical technology company specializing in the development of AI-driven solutions to predict postprandial blood glucose levels for type 2 diabetes patients. Its application analyzes biometric data and daily activities, empowering users with personalized health insights to make informed lifestyle changes.

Spectee operates an online news platform that curates and publishes real-time social media user-generated video content. Utilizing proprietary AI technology, Spectee accelerates news analysis and delivery, focusing on significant events like natural disasters. It collaborates with other companies to enhance its service and licenses content for broadcasters.

ARCS specializes in developing assisted reproductive medical devices using robotics and artificial intelligence technology.